China Bioligic Products Stock Price - CBPO

110.77
0.00 (0.0%)
110.77
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
China Bioligic Products Holdings Inc CBPO NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 110.77 0.00 0.00 0.00 110.77 20:00:00
Bid Price Ask Price Spread Spread % News
78.54 115.00 36.46 31.7% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 110.77 USD

China Bioligic Products Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.26B 38.48M 29.97M $ 503.74M $ 169.91M 3.53 27.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 22.10%

more financials information »

China Bioligic Products News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CBPO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week107.16110.825105.7773109.0668,7453.613.37%
1 Month105.15111.5799104.68108.6173,4205.625.34%
3 Months113.85116.5097.91106.64121,418-3.08-2.71%
6 Months116.69118.3097.91111.17105,575-5.92-5.07%
1 Year89.98119.4488.00107.42118,60720.7923.11%
3 Years114.00119.4460.0891.33210,083-3.23-2.83%
5 Years112.00144.289960.08100.30212,496-1.23-1.1%

China Bioligic Products Description

China Biologic Products Holdings Inc is a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based products in China. The company operates its business through two majority owned subsidiaries, Shandong Taibang and Guizhou Taibang. China Biologic's product pipeline includes a variety of dosages across multiple product categories. Its principal products are human albumin and immunoglobulin for intravenous injection. All of the company's products are prescription medicines administered in the form of injections. China Biologic's sales model focuses on direct sales to hospitals and inoculation centers and is complemented by distributor sales.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.